Pesquisas alternativas:
"gesto en" » "gesto e" (Expandir a Pesquisa), "gesto de" (Expandir a Pesquisa), "gesto y" (Expandir a Pesquisa), "gestoy en" (Expandir a Pesquisa), "gresto en" (Expandir a Pesquisa), "gestos en" (Expandir a Pesquisa)
"eo open" » "neo open" (Expandir a Pesquisa), "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa)
"esto en" » "estoy en" (Expandir a Pesquisa), "resto en" (Expandir a Pesquisa), "estos en" (Expandir a Pesquisa)
"so open" » "do open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "o open" (Expandir a Pesquisa)
"esmo open" » "eso open" (Expandir a Pesquisa), "ecmo open" (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 2,058 para a pesquisa '(((("eo open") OR ((("esmo open") OR ((("esto en") OR ("gesto en"))))))) OR ("so open"))', tempo de pesquisa: 2.48seg Refinar resultados
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
ESMO Open—Cancer Horizons and the future of oncology

CSCO joins ESMO Open—Cancer Horizons
ESMO Open: news in breast cancer 2019

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
ESMO Open special series on new emerging targets in cancer immunotherapy

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
One year of ESMO Open: Cancer Horizons—where are we going from here?

HUELLAS DEL GESTO EN EL DISCURSO
HUELLAS DEL GESTO EN EL DISCURSO

Plasmodesmata. A Not So Open-and-Shut Case
DOS CENAS FUNDACIONALES: HACED ESTO EN MEMORIA MÍA

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy
Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
La repetición del gesto en el discurso interactivo

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]
El rol de los gestos en la construcción de significados en el aula

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa